Anebulo Pharmaceuticals, Inc. (ANEB) Tops Q2 EPS by 8c

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q2 EPS of ($0.05), $0.08 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

You May Also Be Interested In

• Stifel Reiterates Hold Rating on Nike (NKE)
• UBS Upgrades Smoore International Holdings Limited (6969:HK) (SMORF) to Buy
• Jefferies Downgrades Tyro Payments Limited (TYR:AU) (TYPMF) to Hold